Press Releases

[On-Target] AAV Targeting the Muscle – Serotypes/ Promoters/ Dosages —All You Need in One Guide!
2026-06-12

Muscle tissue is an essential functional component of the body, generating force and movement through cycles of contraction and relaxation — processes fundamental to sustaining life and maintaining postural stability. In vertebrates, muscles are broadly classified into three types: smooth muscle, cardiac muscle, and skeletal muscle. Smooth muscle lines the walls of internal organs, while cardiac muscle is found exclusively in the heart; both contract autonomously without conscious input. Skeletal muscle is the most abundant muscle type and is attached to the skeleton, enabling voluntary movement throughout the body. This article focuses on the application of AAV in skeletal muscle research.



Figure 1. Classification of muscle types in vertebrates (Source: Wikipedia)

 

Skeletal muscle is composed of bundles of muscle fibers, each containing myofibrils made up of myofilaments. The fibers are rich in sarcoplasmic reticulum and mitochondria, which coordinate contraction and energy supply. Commonly studied skeletal muscles include the gastrocnemius, tibialis anterior, soleus, biceps femoris, and quadriceps.





Figure 2. Structural organization of skeletal muscle (PMID: 35631979)




Figure 3. Hind limb skeletal muscle anatomy in mice (PMID: 34867435)


 

Skeletal muscle diseases are diverse in etiology and profoundly impair patients' quality of life. Muscular dystrophies (MD) are a group of inherited disorders characterized by progressive muscle wasting and weakness. The most common and severe form is Duchenne muscular dystrophy (DMD), an X-linked recessive condition that primarily affects males. Symptoms of muscle weakness typically emerge around age 4 and progress rapidly, leading to impaired mobility, eventual dependence on ventilatory support, and premature death. Other active areas of skeletal muscle research include inflammatory myopathies, metabolic myopathies, and mechanisms of muscle regeneration.




Figure 4. Histological comparison of healthy versus DMD muscle tissue (PMID: 33602943)

 

Viral vectors are routinely used in muscle research to deliver genetic material and modulate gene expression in host cells. Recombinant adeno-associated viral vectors (rAAV) are the most widely adopted platform for in vivo gene delivery, offering a broad range of serotypes, low immunogenicity, stable long-term transgene expression, and a wide host range. These properties have made rAAV an invaluable tool in muscle biology research.

 

01  AAV Serotype Selection

A comparative study evaluating AAV serotypes 1–10 in murine skeletal muscle found that AAV9 and AAV8 achieve the highest transduction efficiency. Additionally, systemic delivery of the myoAAV1A serotype via intravenous injection has been shown to preferentially transduce striated muscle — encompassing both skeletal muscle and cardiac muscle.



Figure 5. Striated muscle targeting following intravenous delivery of myoAAV1A in mice (PMID: 34506722)

 

02  Promoter Selection

Achieving muscle-specific transgene expression requires not only a muscle-tropic AAV serotype, but also an appropriate cell-type-specific promoter. The dMCK/tMCK and ACTA1 promoters drive expression selectively in skeletal muscle, while the MHCK7 promoter directs expression across striated muscle (both skeletal and cardiac). Considerable research attention has also focused on myoblasts — muscle progenitor cells that proliferate via mitosis and play a pivotal role in muscle growth and repair. Myoblast-specific transduction can be achieved using the Myog promoter.

 

Recommended AAV Serotypes and Promoters for Muscle Targeting

 

 

AAV Serotypes

Promoters

AAV9 / AAV8

dMCK, tMCK, ACTA1

Skeletal muscle

MHCK7

Striated muscle

Myog

Myoblasts

SM22a / EnSM22a

Smooth muscle

myoAAV1A

CBh / CMV / CAG / U6

Broad infection

Table 1. Recommended AAV serotypes and promoters for muscle-targeted gene delivery

 

03  Injection Routes and Dosing

The two most commonly used delivery methods for AAV-mediated muscle gene transfer are intramuscular injection and tail vein injection. Specific injection parameters are summarized in the table below.

 

AAV Delivery Methods for Muscle-Targeted Gene Transfer

Injection Route

Pros

Cons

AAV Dosage

Intramuscular injection

• High transduction efficiency

• Strong targeting capability

• Invasive, causing tissue damage

• Uneven expression, high expression only around the injection site

~1E+11 vg /side

25 μL /side

Tail vein injection

• Simple operation

• Non-invasive (to the muscle)

• Poor targeting capability

• Low transduction efficiency

~5E+11vg /mouse

100-200 μL

 

Table 2. Injection routes and dosing guidelines for AAV-mediated muscle gene delivery in adult mice

 

04  Application Case Studies


Case Study 1


Sarcopenia is a progressive neuromuscular disorder characterized by age-related muscle atrophy and weakness, yet its molecular mechanisms remain incompletely understood. The study observed that Agrin protein levels in murine skeletal muscle decline with age. Using AAV vectors supplied by OBiO Tech, the researchers delivered a miniaturized Agrin construct to skeletal muscle via overexpression, demonstrating that elevated Agrin levels enhance muscle performance in aged mice. The improvement in muscle function was mediated through activation of Yap signaling and upregulation of dystrophin expression. These findings provide a mechanistic rationale for targeting the Agrin pathway in the treatment of sarcopenia.



 


Figure 6. Agrin overexpression reverses age-related muscle weakness (PMID: 38461287)

 

Parameter

Details

Viral vector

AAV9-CB-mini-Agrin

Animal model

mice

Injection route

Intramuscular injection

Target tissue

Gastrocnemius, tibialis anterior muscle

Dosage

2E+12 vg/mL – 1E +13 vg/mL ,30-50μL

Detection time

5 weeks

 


Case Study 2


A study published in Cell Metabolism describes the development of FiLa — a highly sensitive, fast-responding lactate biosensor capable of detecting subtle lactate fluctuations in living cells and intact animals. The researchers used AAV to introduce the FiLa sensor into murine skeletal muscle, enabling direct visualization of elevated lactate levels in diabetic mice. This technology offers a promising platform for simple and efficient lactate monitoring with potential applications in clinical screening. The AAV constructs used in this study were also produced by OBiO Tech.


Figure 7. The lactate biosensor FiLa shows robust expression in murine skeletal muscle (PMID: 36309010)

 

Parameter

Details

Viral construct

AAV9-CMV-FiLa, AAV9-CMV-FiLa-C

Animal model

C57 mice, db/db mice

Injection route

Intramuscular injection

Target tissue

Gastrocnemius muscle

Dosage

6E +10 vg, 50 μL

Detection time

4-6 weeks

 

References

[1] Fan J, et al. A Review of Recent Advances in Natural Polymer-Based Scaffoldsfor Musculoskeletal Tissue Engineering. Polymers (Basel). 2022;14(10):2097.

[2] Mytidou C, et al. Age-Related Exosomal and Endogenous Expression Patterns ofmiR-1, miR-133a, miR-133b, and miR-206 in Skeletal Muscles. Front Physiol.2021;12:708278.

[3] Duan D, et al. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7(1):13.

[4] Tabebordbar M, et al. Directed evolution of a family of AAV capsid variantsenabling potent muscle-directed gene delivery across species. Cell.2021;184(19):4919-4938.e22.

[5] Chen J, et al. Deficiency of skeletal muscle Agrin contributes to thepathogenesis of age-related sarcopenia in mice. Cell Death Dis. 2024;15(3):201.

[6] Li X, et al. Ultrasensitive sensors reveal the spatiotemporal landscape oflactate metabolism in physiology and disease. Cell Metab.2023;35(1):200-211.e9.

Related recommendations
Request Now
© OBiO Tech, Inc. All Rights Reserved